gastroenterologist-2016_scientifictracks-abstracts

17 / 50

Notes:
Page 32
Gastro 2016
August 11-12, 2016
Volume 6, Issue 4(Suppl) J Gastrointest Dig Syst 2016
ISSN:2161-069X JGDS, an open access journal
conferenceseries .com
August 11-12, 2016 Birmingham, UK
6th Global Gastroenterologists Meeting
Pawan Mathur, J Gastrointest Dig Syst 2016, 6:4(Suppl)
State of the art in Minimally Invasive Colorectal Surgery (MICS)
Pawan Mathur
Royal Free London NHS Fundation Trust, UK
The author will aim to demonstrate the role of MICS in the modern day management of colrectal cancer (CRC). There will
be a discussion regarding the central role of multi disciplinary meetings (MDTs) in the manageemnt of CRC, the reasons
why they exist, who is involved and evidence of their efficacy and outcomes. The increasing role of laparoscopic colorectal
surgery will be discussed in terms of CRC management. Up to date RCT evidence will be presented of both colon and rectal
cancer surgery. The alternate routes of minimally invasive access will be presented (single incision laparoscopic surgery (SILS),
natural orifice extraction surgery (NOSES) and hybrid laparoscopic-endoscopic techniques). Evidences, where it exists, will
be discussed. The role of robotic colorectal surgery will be discussed and randomised evidence in rectal cancer surgery will be
(ROLLAR) prsesented. Results of a prospective study of patiet preference in terms of surgical access routes will be presented.
The management of early rectal cancer will be discussed with trans-anal endocscopic microsurgery (TEMS) and trans anal
microscopic invasive surgery (TaMIS) techniques. The role of endoscopic mucosal/ serosal resection (EMR/ ESR) will also be
discussed in the management of early CRC. The future of MICS is discussed with a projection that this may look like going
into 2017/2018.
Biography
Pawan Mathur, MS FRCS [Gen Surg], is a General, Colorectal & Laparoscopic Surgeon at The Royal Free London NHS Foundation Hospitals. His specialist
interest is in colorectal conditions such as haemorrhoids (piles) anal fissures, anal fistulae, ulcerative colitis/Crohn’s disease, pelvic floor conditions and colorectal
cancer. He qualified from St. Thomas’ Hospital Medical School in 1990. He undertook a Postgraduate Research degree at the Royal Marsden and Chelsea &
Westminster Hospitals and was awarded a MS thesis for his work examining the role of manipulating tumour blood supply on chemotherapeutic drug uptake in
colorectal liver metastases. He maintains an active interest in surgical research and continues to publish in peer-reviewed journals. In this regard, he is Clinical
Research Lead for Surgery in the Trust. He is currently the Principal Investigator on a variety of randomized surgical clinical trials. He also holds an Honarary Senior
Lectureship at UCL Medical School, which allows him to pursue his main research interest in colorectal cancer.